SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-106882
Filing Date
2022-04-15
Accepted
2022-04-15 16:54:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d337200ddefa14a.htm DEFA14A 35506
2 GRAPHIC g337200g36u99.jpg GRAPHIC 10640
3 GRAPHIC g337200g77l76.jpg GRAPHIC 824
4 GRAPHIC g337200sp04.jpg GRAPHIC 42654
  Complete submission text file 0001193125-22-106882.txt   111409
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33137 | Film No.: 22830481
SIC: 2834 Pharmaceutical Preparations